Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Prevention of Disability: Proposal for a Guidance Manual for Leprosy Patients

This study has been completed.
Sponsor:
Collaborator:
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Information provided by:
University of Sao Paulo
ClinicalTrials.gov Identifier:
NCT01006759
First received: November 2, 2009
Last updated: NA
Last verified: November 2009
History: No changes posted
  Purpose

Leprosy is an infectious disease of slow evolution, manifested primarily by signs and symptoms dermatoneurological with skin lesions and peripheral nerve, especially in the eyes, hands and feet. The prevention of disability is essential for the control of complications. Objective: To evaluate the physical and functional status of hands, feet and eyes, for the appearance and evolution of sensory and motor deficiencies and classification of disability (WHO) of a group of leprosy patients to compare and monitor the result treatment on the progression of neuropathy and recurrence of reactions. Methodology: We performed initial physical therapy evaluation and final, after 12 months. We conducted a clinical trial of a series of 26 cases evaluated with newly diagnosed leprosy, treated by standard medication. There were used methods of qualitative and quantitative. An illustrated manual of guidelines was especially developed for this study.


Condition Intervention Phase
Leprosy
Disability Evaluation
Quality of Life
Other: exercise and orientation
Phase 1

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Prevention
Official Title: Proposal Evaluation and Intervention Through Prevention of Disability in Leprosy Patients

Resource links provided by NLM:


Further study details as provided by University of Sao Paulo:

Primary Outcome Measures:
  • classification of disability for Leprosy(WHO) [ Time Frame: 1 year ] [ Designated as safety issue: Yes ]

Secondary Outcome Measures:
  • classification of disability for Leprosy(WHO), grip strength and threshold sensibility [ Time Frame: after 1 year ] [ Designated as safety issue: Yes ]

Enrollment: 55
Study Start Date: January 2007
Study Completion Date: August 2009
Primary Completion Date: December 2008 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: leprosy disability
intervention of a series of cases with leprosy that made treatment in a Clinical Hospital
Other: exercise and orientation
guidances for prevention of disability in leprosy with focus on hands, eyes and feet.
Other Names:
  • prevention of disability
  • guidance
  • orientation
  • promotion of health

Detailed Description:

assessment methods of qualitative and quantitative: inspection of eyes, hands and foot, manual motor function, grip and pinch dynamometry,threshold test, SF 36 quality of life questionnaire.

Intervention: illustrated guidelines, exercises, orthoses, orientation Goals: disability prevention

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • The patients in this project were diagnosed and referred by the dermatology to do the physical-functional evaluation and physiotherapy. We selected patients aged 18 years and both sexes, even with comorbidities, since diagnosed and treated. In accepting to participate in the research, signed a consent form

Exclusion Criteria:

  • Those patients who refused to sign the consent form and those who did not attend the evaluations
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01006759

Locations
Brazil
School of Medicine, University of Sao Paulo
Ribeirao Preto, SP, Brazil, 14049900
Sponsors and Collaborators
University of Sao Paulo
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Investigators
Principal Investigator: Marisa CR Fonseca, PhD University of Sao Paulo
  More Information

Additional Information:
Publications:
Responsible Party: Marisa de Cássia Registro Fonseca, School of Medicine, University of Sao Paulo
ClinicalTrials.gov Identifier: NCT01006759     History of Changes
Other Study ID Numbers: FMRPUSP, HCRP n°14553/2005
Study First Received: November 2, 2009
Last Updated: November 2, 2009
Health Authority: Brazil: Ministry of Health

Keywords provided by University of Sao Paulo:
Leprosy
Disability Evaluation
Quality of Life
Sensation

Additional relevant MeSH terms:
Leprosy
Actinomycetales Infections
Bacterial Infections
Gram-Positive Bacterial Infections
Mycobacterium Infections

ClinicalTrials.gov processed this record on November 24, 2014